Skip to main content
Journal cover image

Prognostic Value of Sarcopenia and Albumin in the Surgical Management of Localized Renal Cell Carcinoma.

Publication ,  Journal Article
Midenberg, E; Higgins, MI; Schmeusser, BN; Patil, DH; Zaldumbide, J; Martini, DJ; Steele, S; Williams, M; Nabavizadeh, R; Psutka, SP; Ogan, K ...
Published in: Urol Oncol
January 2023

INTRODUCTION: A universally accepted model for preoperative surgical risk stratification in localized RCC patients undergoing nephrectomy is currently lacking. Both the evaluation of body composition and nutritional status has demonstrated prognostic value for patients with cancer. This study aims to investigate the potential associations between sarcopenia and hypoalbuminemia and survival outcomes in patients with localized kidney cancer treated with partial or radical nephrectomy. MATERIALS AND METHODS: We retrospectively analyzed 473 patients with localized RCC managed with radical and partial nephrectomy. Skeletal muscle index (SMI) was measured from preoperative CT and MRI. Sarcopenic criteria were created using BMI- and sex-stratified thresholds. Relationships between sarcopenia and hypoalbuminemia (Albumin <3.5 g/dL) with overall (OS), recurrence-free (RFS), and cancer-specific survival (CSS) were determined using multivariable and Kaplan-Meier analysis. RESULTS: Of the 473 patients, 42.5% were sarcopenic and 24.5% had hypoalbuminemia. Sarcopenia was significantly associated with shorter OS (HR=1.51, 95% CI 1.07-2.13), however, was nonsignificant in the RFS (HR = 1.33, 95% CI 0.88-2.03) and CSS (HR=1.66, 95% CI 0.96-2.87) models. Hypoalbuminemia predicted shorter OS (HR=1.76, 95% CI 1.22-2.55), RFS (HR=1.86, 95% CI 1.19-2.89), and CSS (HR=1.82, 95% CI 1.03-3.22). Patients were then stratified into low, medium, and high-risk groups based on the severity of sarcopenia and hypoalbuminemia. Risk groups demonstrated an increasing association with shorter OS (all p<0.05). Reduced RFS was observed in the medium risk-hypoalbuminemia (HR=2.18, 95% CI 1.16-4.09) and high-risk groups (HR=2.42, 95% CI 1.34-4.39). Shorter CSS was observed in the medium risk-hypoalbuminemia (HR=2.31, 95% CI 1.00-5.30) and high-risk groups (HR=2.98, 95% CI 1.34-6.61). CONCLUSION: Localized RCC patients with combined preoperative sarcopenia and hypoalbuminemia displayed a two to a three-fold reduction in OS, RFS, and CSS after nephrectomy. These data have implications for guiding prognostication and treatment election in localized RCC patients undergoing extirpative surgery.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Urol Oncol

DOI

EISSN

1873-2496

Publication Date

January 2023

Volume

41

Issue

1

Start / End Page

50.e19 / 50.e26

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • Sarcopenia
  • Retrospective Studies
  • Prognosis
  • Nephrectomy
  • Kidney Neoplasms
  • Hypoalbuminemia
  • Humans
  • Carcinoma, Renal Cell
  • Albumins
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Midenberg, E., Higgins, M. I., Schmeusser, B. N., Patil, D. H., Zaldumbide, J., Martini, D. J., … Master, V. A. (2023). Prognostic Value of Sarcopenia and Albumin in the Surgical Management of Localized Renal Cell Carcinoma. Urol Oncol, 41(1), 50.e19-50.e26. https://doi.org/10.1016/j.urolonc.2022.09.020
Midenberg, Eric, Michelle I. Higgins, Benjamin N. Schmeusser, Dattatraya H. Patil, Joel Zaldumbide, Dylan J. Martini, Sean Steele, et al. “Prognostic Value of Sarcopenia and Albumin in the Surgical Management of Localized Renal Cell Carcinoma.Urol Oncol 41, no. 1 (January 2023): 50.e19-50.e26. https://doi.org/10.1016/j.urolonc.2022.09.020.
Midenberg E, Higgins MI, Schmeusser BN, Patil DH, Zaldumbide J, Martini DJ, et al. Prognostic Value of Sarcopenia and Albumin in the Surgical Management of Localized Renal Cell Carcinoma. Urol Oncol. 2023 Jan;41(1):50.e19-50.e26.
Midenberg, Eric, et al. “Prognostic Value of Sarcopenia and Albumin in the Surgical Management of Localized Renal Cell Carcinoma.Urol Oncol, vol. 41, no. 1, Jan. 2023, pp. 50.e19-50.e26. Pubmed, doi:10.1016/j.urolonc.2022.09.020.
Midenberg E, Higgins MI, Schmeusser BN, Patil DH, Zaldumbide J, Martini DJ, Steele S, Williams M, Nabavizadeh R, Psutka SP, Ogan K, Bilen MA, Master VA. Prognostic Value of Sarcopenia and Albumin in the Surgical Management of Localized Renal Cell Carcinoma. Urol Oncol. 2023 Jan;41(1):50.e19-50.e26.
Journal cover image

Published In

Urol Oncol

DOI

EISSN

1873-2496

Publication Date

January 2023

Volume

41

Issue

1

Start / End Page

50.e19 / 50.e26

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • Sarcopenia
  • Retrospective Studies
  • Prognosis
  • Nephrectomy
  • Kidney Neoplasms
  • Hypoalbuminemia
  • Humans
  • Carcinoma, Renal Cell
  • Albumins